Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
Behavioural Brain Research
|
September 11, 2022
Altered EEG power spectrum, but not sleep-wake architecture, in HCN1 knockout mice
Lauren E Bleakley, Ryan J Keenan, Rachel D Graven, et al.
Journal of Medicinal Chemistry
|
October 14, 2021
Discovery of Umibecestat (CNP520): A Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor for the Prevention of Alzheimer's Disease
Rainer Machauer, Rainer Lueoend, Konstanze Hurth, et al.
Journal of Medicinal Chemistry
|
August 23, 2013
Identification of a novel series of orexin receptor antagonists with a distinct effect on sleep architecture for the treatment of insomnia
Claudia Betschart, Samuel Hintermann, Dirk Behnke, et al.
Journal of Medicinal Chemistry
|
April 12, 2021
Synthesis of the Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor NB-360
Heinrich Rueeger, Rainer Lueoend, Rainer Machauer, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 3, 2015
Discovery of 1H-pyrazolo[3,4-b]pyridines as potent dual orexin receptor antagonists (DORAs)
Dirk Behnke, Simona Cotesta, Samuel Hintermann, et al.
Molecular Neurodegeneration
|
September 5, 2015
A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice
Ulf Neumann, Heinrich Rueeger, Rainer Machauer, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 24, 2011
The second-generation active Aβ immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effects
Christoph Wiessner, Karl-Heinz Wiederhold, Alain C Tissot, et al.
Neurobiology of Aging
|
July 28, 2016
Longitudinal noninvasive magnetic resonance imaging of brain microhemorrhages in BACE inhibitor-treated APP transgenic mice
Nicolau Beckmann, Arno Doelemeyer, Stefan Zurbruegg, et al.
British Journal of Pharmacology
|
August 9, 2023
Orexin 2 receptor antagonism sex-dependently improves sleep/wakefulness and cognitive performance in tau transgenic mice
Ryan J Keenan, Heather Daykin, Jeremy Metha, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
July 24, 2024
Acoustic Stimulation to Improve Slow-Wave Sleep in Alzheimer's Disease: A Multiple Night At-Home Intervention
Laura Van den Bulcke, Hannah Davidoff, Elisabeth Heremans, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
Behavioural Brain Research
|
September 11, 2022
Altered EEG power spectrum, but not sleep-wake architecture, in HCN1 knockout mice
Lauren E Bleakley, Ryan J Keenan, Rachel D Graven, et al.
Journal of Medicinal Chemistry
|
October 14, 2021
Discovery of Umibecestat (CNP520): A Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor for the Prevention of Alzheimer's Disease
Rainer Machauer, Rainer Lueoend, Konstanze Hurth, et al.
Journal of Medicinal Chemistry
|
August 23, 2013
Identification of a novel series of orexin receptor antagonists with a distinct effect on sleep architecture for the treatment of insomnia
Claudia Betschart, Samuel Hintermann, Dirk Behnke, et al.
Journal of Medicinal Chemistry
|
April 12, 2021
Synthesis of the Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor NB-360
Heinrich Rueeger, Rainer Lueoend, Rainer Machauer, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 3, 2015
Discovery of 1H-pyrazolo[3,4-b]pyridines as potent dual orexin receptor antagonists (DORAs)
Dirk Behnke, Simona Cotesta, Samuel Hintermann, et al.
Molecular Neurodegeneration
|
September 5, 2015
A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice
Ulf Neumann, Heinrich Rueeger, Rainer Machauer, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 24, 2011
The second-generation active Aβ immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effects
Christoph Wiessner, Karl-Heinz Wiederhold, Alain C Tissot, et al.
Neurobiology of Aging
|
July 28, 2016
Longitudinal noninvasive magnetic resonance imaging of brain microhemorrhages in BACE inhibitor-treated APP transgenic mice
Nicolau Beckmann, Arno Doelemeyer, Stefan Zurbruegg, et al.
British Journal of Pharmacology
|
August 9, 2023
Orexin 2 receptor antagonism sex-dependently improves sleep/wakefulness and cognitive performance in tau transgenic mice
Ryan J Keenan, Heather Daykin, Jeremy Metha, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
July 24, 2024
Acoustic Stimulation to Improve Slow-Wave Sleep in Alzheimer's Disease: A Multiple Night At-Home Intervention
Laura Van den Bulcke, Hannah Davidoff, Elisabeth Heremans, et al.
Page
of 7